1. Home
  2. EDSA vs SYNX Comparison

EDSA vs SYNX Comparison

Compare EDSA & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • SYNX
  • Stock Information
  • Founded
  • EDSA 2015
  • SYNX 2005
  • Country
  • EDSA Canada
  • SYNX Israel
  • Employees
  • EDSA N/A
  • SYNX N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • SYNX
  • Sector
  • EDSA Health Care
  • SYNX
  • Exchange
  • EDSA Nasdaq
  • SYNX Nasdaq
  • Market Cap
  • EDSA 13.8M
  • SYNX 13.7M
  • IPO Year
  • EDSA N/A
  • SYNX 2024
  • Fundamental
  • Price
  • EDSA $2.03
  • SYNX $1.69
  • Analyst Decision
  • EDSA Strong Buy
  • SYNX
  • Analyst Count
  • EDSA 2
  • SYNX 0
  • Target Price
  • EDSA $13.00
  • SYNX N/A
  • AVG Volume (30 Days)
  • EDSA 33.4K
  • SYNX 128.8K
  • Earning Date
  • EDSA 08-08-2025
  • SYNX 05-14-2025
  • Dividend Yield
  • EDSA N/A
  • SYNX N/A
  • EPS Growth
  • EDSA N/A
  • SYNX N/A
  • EPS
  • EDSA N/A
  • SYNX N/A
  • Revenue
  • EDSA N/A
  • SYNX $9,094,000.00
  • Revenue This Year
  • EDSA N/A
  • SYNX $32.35
  • Revenue Next Year
  • EDSA N/A
  • SYNX N/A
  • P/E Ratio
  • EDSA N/A
  • SYNX N/A
  • Revenue Growth
  • EDSA N/A
  • SYNX 19.14
  • 52 Week Low
  • EDSA $1.55
  • SYNX $1.65
  • 52 Week High
  • EDSA $5.59
  • SYNX $6.49
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 52.89
  • SYNX 48.15
  • Support Level
  • EDSA $1.91
  • SYNX $1.67
  • Resistance Level
  • EDSA $2.14
  • SYNX $1.91
  • Average True Range (ATR)
  • EDSA 0.12
  • SYNX 0.20
  • MACD
  • EDSA 0.02
  • SYNX 0.02
  • Stochastic Oscillator
  • EDSA 64.52
  • SYNX 22.21

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

Share on Social Networks: